Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Community leaders step up to boost COVID shots in black rheumatic patients

NCT ID NCT05822219

First seen Jun 05, 2026 · Last updated Jun 14, 2026 · Updated 2 times

Summary

This study tests whether training popular community leaders to share vaccine information can increase COVID-19 booster shots among Black individuals with rheumatic conditions like lupus. About 60 people will take part, including leaders and their social network members. The goal is to reduce vaccine hesitancy and improve uptake through trusted community voices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Northwestern University

    Chicago, Illinois, 60611, United States

Conditions

The condition(s) this trial relates to.

COVID-19 rheumatic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.